voize vs Idexx Laboratories

Side-by-side comparison of AI visibility scores, market position, and capabilities

Idexx Laboratories leads in AI visibility (94 vs 39)
voize logo

voize

EmergingHealthcare

General

Berlin AI voice documentation for 600+ nursing care facilities saving 39 min/shift at Charité; YC W22 $9M HV Capital-backed competing with Nuance DAX for healthcare documentation automation at $9.4M revenue.

AI VisibilityBeta
Overall Score
D39
Category Rank
#804 of 1158
AI Consensus
91%
Trend
up
Per Platform
ChatGPT
44
Perplexity
46
Gemini
46

About

voize is a Berlin-based healthtech company — backed by Y Combinator (W22) with $9 million raised in a seed round led by HV Capital with redalpine and HPI Ventures — providing AI-powered voice documentation software that enables nurses and healthcare workers to dictate patient reports, vital signs, and care notes directly into smartphones, replacing the manual keyboard data entry that currently consumes 20-40% of nursing shift time in care facilities. Founded in 2021, voize serves 600+ care facilities in Germany (including Charité University Hospital, which measured a 39-minute time savings per nurse per shift after deploying voize), generating $9.4 million in revenue in 2024 with a 35-person team by targeting the structural documentation burden that is driving nursing workforce burnout and contributing to staff shortages across European healthcare systems.

Full profile
Idexx Laboratories logo

Idexx Laboratories

LeaderHealthcare Tech

Enterprise

Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.

AI VisibilityBeta
Overall Score
A94
Category Rank
#19 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
92
Gemini
88

About

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.

Full profile

AI Visibility Head-to-Head

39
Overall Score
94
#804
Category Rank
#19
91
AI Consensus
71
up
Trend
stable
44
ChatGPT
99
46
Perplexity
92
46
Gemini
88
46
Claude
94
48
Grok
99

Key Details

Category
General
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.